You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 122 No. 12, December 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE ANNUAL MEETING OF THE SOCIETY OF SURGICAL ONCOLOGY, LONDON, APRIL 27 TO APRIL 30, 1987-PART II
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (33)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Surgical Treatment of Lymph Nodes With Metastatic Melanoma From Unknown Primary Site

Jan H. Wong, MD; Leslie A. Cagle, MD; Donald L. Morton, MD

Arch Surg. 1987;122(12):1380-1383.


Abstract

• To determine the prognosis of patients with lymph node metastases from an unknown primary melanoma, we retrospectively reviewed the clinicopathologic features of 188 such patients treated from 1971 through 1986 and compared their records with those of patients with clinical stage II melanoma with known primary lesions. Patients with lymph node metastases from an unknown primary melanoma represented 4.6% of all patients with melanoma treated during that period. The five- and ten-year survival rates were 42% and 40%, respectively (median, 37 months). When stratified by number of tumor-containing lymph nodes, there was no significant difference in survival between patients with an unknown primary melanoma and lymph node metastases and those with clinical stage II melanoma and known primary sites. The prognosis of the former patients is no worse than that of patients with lymph node metastases from a known primary site and should be treated in a comparable manner.

(Arch Surg 1987;122:1380-1383)



Author Affiliations

From the Division of Surgical Oncology, John Wayne Cancer Clinic, Armand Hammer Laboratories, and Jonsson Comprehensive Cancer Center, UCLA School of Medicine, Los Angeles.


Footnotes

Accepted for publication July 16, 1987.

Read before the Annual Meeting of the Society of Surgical Oncology, London, April 27, 1987.

Reprint requests to Division of Surgical Oncology, Louis Factor Building, Ninth Floor, UCLA School of Medicine, Los Angeles, CA 90024 (Dr Wong).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gastrointestinal Bleeding as Initial Presentation of Melanoma of Unknown Primary Origin: Report of a Case and Review of the Literature
KOTTEAS et al.
In Vivo 2009;23:487-489.
ABSTRACT | FULL TEXT  

Improved Survival After Lymphadenectomy for Nodal Metastasis From an Unknown Primary Melanoma
Lee et al.
JCO 2008;26:535-541.
ABSTRACT | FULL TEXT  

Malignant Melanoma in the 21st Century, Part 2: Staging, Prognosis, and Treatment
Markovic et al.
Mayo Clin Proc. 2007;82:490-513.
ABSTRACT | FULL TEXT  

Complete Regression of Primary Cutaneous Malignant Melanoma
Menzies and McCarthy
Arch Surg 1997;132:553-556.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.